Eli Lilly and Company (LLY) Unveils AI Platform to Enhance Drug Discovery
Eli Lilly and Co. (NYSE:LLY) is one of the best defensive stocks to buy, according to Steve Cohen. On September 9, the company announced the launch of an artificial intelligence and machine learning platform. Eli Lilly and Company (LLY) Unveils AI Platform to Enhance Drug Discovery Pixabay/Public Domain TuneLab is the platform that consists of AI models and proprietary data obtained at a cost of more than $1 billion. The platform is designed to provide biotech companies with all the necessary models tra ...